Email
Print
Age Related Macular Degeneration Market - Forecast(2024 - 2030)
Overview
Age related Macular
Degeneration Market is projected to reach revenue of $12.85 billion by 2025, and is estimated to grow at a CAGR of 7.7%
during the forecast period 2019-2025. The Age
Related Macular Degeneration market size, in 2018, is said to be $7.65 billion.
Age related macular degeneration is a medical condition of the eye which
diminishes the eyesight with age. Thus a rising geriatric population will
contribute to growth of this market.
Key Takeaways
- The market is estimated to
grow at a CAGR of 7.7% owing to the rising prevalence of AMD along with rise in geriatric
population.
- Companies are adopting various strategic alliances to expand in various regions. Investments in research have increased in order to develop treatment drugs for AMD.
- Rare case of macular degeneration occur in children, teenagers, or adults, called the Stargardt disease, which is an inherited retinal disorder.
Product Type - Segment Analysis
AMD is of two types; dry and
wet AMD. Dry AMD is caused by the formation of deposits called under the
retina; and, wet AMD is caused by abnormal growth of the blood vessels beneath
the macula. Wet AMD accounts for larger share in the market owing to rising
prevalence of this compared to dry AMD among the geriatric population. This
segment also has a growth rate of 7% and is growing faster than the dry AMD
segment.
Drug - Segment Analysis
Wet AMD has drugs for its
treatment, whereas dry AMD has no available treatment. The drugs used for wet
AMD include anti-Vascular Endothelial Growth Factor drugs (anti-VEGF). Commonly
used drugs are Lucentis (ranibizumab) and Eylea (aflibercept) that are FDA-approved
for the treatment of AMD. Off label drug Avastin (bevacizumab) is also
popularly used. Photodynamic therapy (PDT) is also being used as a treatment
for wet AMD and it slows the damage to vision.
Route of Administration - Segment Analysis
On the basis of route of
administration, the market is segmented into intravenous and intravitreal. The
intravitreal segment is said to dominate the market owing as it is more
effective due to targeted drug delivery. Also, most anti-VEGF injections are
administered using intravitreal or intraocular injections.
Geography - Segment Analysis
In 2018, North America held
43.5% of the global Age-Related Macular Degeneration market share. This is owing to the
increasing prevalence of AMD as well as the rising number of drug approvals in
the country. According to the United States Census Bureau, the older population
is estimated to grow significantly in the coming years. As a result, the prevalence
of age related macular degeneration is also growing. This will lead to the growth
of the market as this region's population will have an increased demand for these
treatments.
Drivers – Age Related Macular Degeneration Market
- Growing geriatric population
and prevalence of eye disorders among them
As per World Bank statistics, 8.873% of the global population belong to
age category 65 years and above, in 2018. AMD is found to affect patients of
the age 60 and above. Thus with rising aging population, the prevalence of AMD
will also increase and will contribute to the market growth.
- Increase in pipeline drugs
for AMD
With no actual cure for AMD,
pharmaceutical companies are developing various drugs for the treatment. Thus a
number of drugs are in the pipeline undergoing development and trials for the treatment
of AMD. Anti VEGF therapies are effective in treatment of wet AMD as they drain
out the fluid leak and restore vision.
Challenges – Age Related Macular Deg eneration Market
- Increase in off label drug
use due to high cost of on-label drugs
The increasing off-label use
of drugs has hindered the growth of the market. Off-label drugs are the use of
medicine for disease or medical condition, in a way or dose that has not been
approved by the Food and Drug Administration (FDA). In the case of AMD, it is
found that the use of Avastin (an off-label drug developed for cancer) is more
popular than Lucentis, which costs more.
Age Related Macular Degeneration Industry Outlook
Research & development along
with strategic alliances are some of the key strategies adopted by players in
the Age Related Macular Degeneration market. Age Related Macular Degeneration
top 10 companies are F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron
Pharmaceutical Inc., Pfizer Inc., Bayer AG, Ophthotech Corporation, GlaxoSmithKline plc,
Neurotech Pharmaceuticals Inc., Alimera Sciences Inc., and StemCells Inc.
Age Related Macular Degeneration Market Research Scope:
The base year of the study
is 2018, with forecast done up to 2025. The study presents a thorough analysis
of the competitive landscape, taking into account the market shares of the
leading companies. These provide the key market participants with the necessary
business intelligence and help them understand the future of the Age Related
Macular Degeneration Market. The assessment includes the forecast, an overview
of the competitive structure, the market shares of the competitors, as well as
the market trends, market demands, market drivers, market challenges, and
product analysis. The market drivers and restraints have been assessed to
fathom their impact over the forecast period. This report further identifies
the key opportunities for growth while also detailing the key challenges and
possible threats.
For more Lifesciences and Healthcare related reports,
please click here
1.1 Definitions and Scope
2. Age Related Macular Degeneration Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Age Related Macular Degeneration Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Age Related Macular Degeneration Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Age Related Macular Degeneration Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Age Related Macular Degeneration Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Age Related Macular Degeneration Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Age Related Macular Degeneration Market - By Product Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Wet Amd
8.3.2 Dry Amd
9. Age Related Macular Degeneration Market - By Drug (Market Size -$Million / $Billion)
9.1 Lucentis
9.2 Eylea
9.3 Avastin
10. Age Related Macular Degeneration - By Route Of Administration (Market Size -$Million / $Billion)
10.1 Intraveous
10.2 Intravitreal
11. Age Related Macular Degeneration- By Geography (Market Size -$Million / $Billion)
11.1 Age Related Macular Degeneration Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Age Related Macular Degeneration- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Age Related Macular Degeneration- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Age Related Macular Degeneration - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong Kong
11.8.5.9 Rest of APAC
11.9 Age Related Macular Degeneration - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Age Related Macular Degeneration Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Age Related Macular Degeneration Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Age Related Macular Degeneration Market - Key Company List by Country Premium
15. Age Related Macular Degeneration Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 F. Hoffmann-La Roche
15.3 Novartis Ag
15.4 Pfizer Inc.
15.5 Regeneron Pharmaceutical
15.6 Valeant Pharmaceutical International, Inc
15.7 Company 6
15.8 Company 7 & More
16.1 Abbreviations
16.2 Sources
17. Age Related Macular Degeneration Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Age Related Macular Degeneration Market, By Product Type Market 2023-2030 ($M)1.1 Wet Amd Market 2023-2030 ($M) - Global Industry Research
1.2 Dry Amd Market 2023-2030 ($M) - Global Industry Research
2.Global Age Related Macular Degeneration Market, By Drug Market 2023-2030 ($M)
2.1 Lucentis Market 2023-2030 ($M) - Global Industry Research
2.2 Eylea Market 2023-2030 ($M) - Global Industry Research
2.3 Avastin Market 2023-2030 ($M) - Global Industry Research
3.Global Age Related Macular Degeneration Market, By Route Of Administration Market 2023-2030 ($M)
3.1 Intraveous Market 2023-2030 ($M) - Global Industry Research
3.2 Intravitreal Market 2023-2030 ($M) - Global Industry Research
4.Global Age Related Macular Degeneration Market, By Product Type Market 2023-2030 (Volume/Units)
4.1 Wet Amd Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Dry Amd Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global Age Related Macular Degeneration Market, By Drug Market 2023-2030 (Volume/Units)
5.1 Lucentis Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Eylea Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Avastin Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Age Related Macular Degeneration Market, By Route Of Administration Market 2023-2030 (Volume/Units)
6.1 Intraveous Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Intravitreal Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America Age Related Macular Degeneration Market, By Product Type Market 2023-2030 ($M)
7.1 Wet Amd Market 2023-2030 ($M) - Regional Industry Research
7.2 Dry Amd Market 2023-2030 ($M) - Regional Industry Research
8.North America Age Related Macular Degeneration Market, By Drug Market 2023-2030 ($M)
8.1 Lucentis Market 2023-2030 ($M) - Regional Industry Research
8.2 Eylea Market 2023-2030 ($M) - Regional Industry Research
8.3 Avastin Market 2023-2030 ($M) - Regional Industry Research
9.North America Age Related Macular Degeneration Market, By Route Of Administration Market 2023-2030 ($M)
9.1 Intraveous Market 2023-2030 ($M) - Regional Industry Research
9.2 Intravitreal Market 2023-2030 ($M) - Regional Industry Research
10.South America Age Related Macular Degeneration Market, By Product Type Market 2023-2030 ($M)
10.1 Wet Amd Market 2023-2030 ($M) - Regional Industry Research
10.2 Dry Amd Market 2023-2030 ($M) - Regional Industry Research
11.South America Age Related Macular Degeneration Market, By Drug Market 2023-2030 ($M)
11.1 Lucentis Market 2023-2030 ($M) - Regional Industry Research
11.2 Eylea Market 2023-2030 ($M) - Regional Industry Research
11.3 Avastin Market 2023-2030 ($M) - Regional Industry Research
12.South America Age Related Macular Degeneration Market, By Route Of Administration Market 2023-2030 ($M)
12.1 Intraveous Market 2023-2030 ($M) - Regional Industry Research
12.2 Intravitreal Market 2023-2030 ($M) - Regional Industry Research
13.Europe Age Related Macular Degeneration Market, By Product Type Market 2023-2030 ($M)
13.1 Wet Amd Market 2023-2030 ($M) - Regional Industry Research
13.2 Dry Amd Market 2023-2030 ($M) - Regional Industry Research
14.Europe Age Related Macular Degeneration Market, By Drug Market 2023-2030 ($M)
14.1 Lucentis Market 2023-2030 ($M) - Regional Industry Research
14.2 Eylea Market 2023-2030 ($M) - Regional Industry Research
14.3 Avastin Market 2023-2030 ($M) - Regional Industry Research
15.Europe Age Related Macular Degeneration Market, By Route Of Administration Market 2023-2030 ($M)
15.1 Intraveous Market 2023-2030 ($M) - Regional Industry Research
15.2 Intravitreal Market 2023-2030 ($M) - Regional Industry Research
16.APAC Age Related Macular Degeneration Market, By Product Type Market 2023-2030 ($M)
16.1 Wet Amd Market 2023-2030 ($M) - Regional Industry Research
16.2 Dry Amd Market 2023-2030 ($M) - Regional Industry Research
17.APAC Age Related Macular Degeneration Market, By Drug Market 2023-2030 ($M)
17.1 Lucentis Market 2023-2030 ($M) - Regional Industry Research
17.2 Eylea Market 2023-2030 ($M) - Regional Industry Research
17.3 Avastin Market 2023-2030 ($M) - Regional Industry Research
18.APAC Age Related Macular Degeneration Market, By Route Of Administration Market 2023-2030 ($M)
18.1 Intraveous Market 2023-2030 ($M) - Regional Industry Research
18.2 Intravitreal Market 2023-2030 ($M) - Regional Industry Research
19.MENA Age Related Macular Degeneration Market, By Product Type Market 2023-2030 ($M)
19.1 Wet Amd Market 2023-2030 ($M) - Regional Industry Research
19.2 Dry Amd Market 2023-2030 ($M) - Regional Industry Research
20.MENA Age Related Macular Degeneration Market, By Drug Market 2023-2030 ($M)
20.1 Lucentis Market 2023-2030 ($M) - Regional Industry Research
20.2 Eylea Market 2023-2030 ($M) - Regional Industry Research
20.3 Avastin Market 2023-2030 ($M) - Regional Industry Research
21.MENA Age Related Macular Degeneration Market, By Route Of Administration Market 2023-2030 ($M)
21.1 Intraveous Market 2023-2030 ($M) - Regional Industry Research
21.2 Intravitreal Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)2.Canada Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
3.Mexico Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
4.Brazil Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
5.Argentina Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
6.Peru Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
7.Colombia Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
8.Chile Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
9.Rest of South America Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
10.UK Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
11.Germany Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
12.France Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
13.Italy Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
14.Spain Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
15.Rest of Europe Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
16.China Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
17.India Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
18.Japan Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
19.South Korea Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
20.South Africa Age Related Macular Degeneration Market Revenue, 2023-2030 ($M)
21.North America Age Related Macular Degeneration By Application
22.South America Age Related Macular Degeneration By Application
23.Europe Age Related Macular Degeneration By Application
24.APAC Age Related Macular Degeneration By Application
25.MENA Age Related Macular Degeneration By Application
26.F. Hoffmann-La Roche, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Regeneron Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Valeant Pharmaceutical International, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Pfizer Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)